Assisted Reproductive Technologies and Increased Autism Risk
Assisted Reproductive Technologies and Increased Autism Risk
批准号:
8301348
负责人:
Peter Shawn Bearman
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-15 至 2014-03-31
关键词:
AccountingAgeAlgorithmsAssisted Reproductive TechnologyAutistic DisorderBehaviorBenefits and RisksBiologicalBirthCaliforniaCenters for Disease Control and Prevention (U.S.)CharacteristicsChildClinicCodeDataData SetDecision MakingDevelopmentDiagnosticEmbryoEtiologyFamily CharacteristicsFertilityFertilization in VitroGeneral PopulationGoalsHealth PersonnelIndividualInfertilityLife Cycle StagesLinkMethodsOther GeneticsOutcomeParental AgesParentsPathway interactionsPersonsPlayPopulationPopulation CharacteristicsPrevalenceProceduresProtocols documentationPublic HealthRegistriesRelative RisksReportingResearchRiskRisk FactorsRoleSample SizeSamplingSecurityServicesSiblingsSourceSystemTimeTwin Multiple BirthWorkdesignegghigh riskmodifiable riskreproductiveresidence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project will link an existing population level dataset consisting of all California births between 1996 and 2006 (over five million children, over
60,000 twin pairs, and over 1 million full and half sibling groups) and outcome data on autism and receipt of developmental services to the CDC's National Assisted Reproductive Technology Surveillance System registry for California infertility clinics for the same period. We will use ths detailed dataset from a large ethnically and geographically diverse state to assess the relationship, if any, between Assisted Reproductive Technology (ART), including in vitro fertilization and related procedures, and autism and to identify the pathways through which this association operates. ART and autism have both increased rapidly in recent decades, and although a relationship is widely suspected, existing research has reported mixed and inconclusive findings, largely a result of insufficient samples. Our design, which enables us to identify about 50,000 ART births and about 24,000 cases of autistic disorder over ten consecutive years, overcomes previous limitations and promises to enable an accurate estimation of autism risk associated with ART. Further, the detailed information we will have on child, parent and family characteristics, residence at birth, ART methods and procedures, and autism outcomes will allow us to better understand the mechanisms at play. With this information, we can 1) identify whether such an association is confounded by individual characteristics selective for both autism and ART, such as parental age, SES, and infertility factors; 2) identify whether an observed association between ART and autism is uniform across ART protocols or is specific to certain method(s); 3) explore the role of clinic-level factors; and
4) ascertain the temporal and spatial correlates of the association of ART and autism. Against the background of rapidly rising autism prevalence and the increasingly important role of ART in reproductive decision-making, this research has important scientific and public health implications. This project has the potential to make significant contributions to our understanding
of the etiology of autism as well as the long-term outcomes of ART births, neither of which are well understood.
PUBLIC HEALTH RELEVANCE: The prevalence of autism has increased rapidly over the last three decades, although its causes remain poorly understood; meanwhile the use of Assisted Reproductive Technology (ART) has also increased dramatically, although the long-term risks to children conceived this way remain largely unknown. This project will contribute to public health by creating a unique population- level dataset designed to ascertain any potential association between ART or its subtypes and autism as well as identify the mechanisms of the association. This will better enable individuals and their health care providers to weigh the risks and benefits
of ART procedures and to recognize a potentially modifiable risk factor for autism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assisted Reproductive Technologies and Risk of Autism and Other Developmental Disabilities
-
批准号:10000188
-
项目类别:
-
资助金额:$51.28万
-
财政年份:2018
-
负责人:Peter Shawn Bearman
-
依托单位:
The Spread of Autism Diagnosis through Spatially Embedded Social Networks
-
批准号:8638261
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2014
-
负责人:Peter Shawn Bearman
-
依托单位:
The Spread of Autism Diagnosis through Spatially Embedded Social Networks
-
批准号:8786111
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2014
-
负责人:Peter Shawn Bearman
-
依托单位:
Assisted Reproductive Technologies and Increased Autism Risk
-
批准号:8458931
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2012
-
负责人:Peter Shawn Bearman
-
依托单位:
Social Determinants of the Autism Epidemic
-
批准号:7341534
-
项目类别:
-
资助金额:$80.5万
-
财政年份:2007
-
负责人:Peter Shawn Bearman
-
依托单位:
Social Determinants of the Autism Epidemic
-
批准号:7660331
-
项目类别:
-
资助金额:$80.5万
-
财政年份:2007
-
负责人:Peter Shawn Bearman
-
依托单位:
Social Determinants of the Autism Epidemic
-
批准号:7914306
-
项目类别:
-
资助金额:$80.5万
-
财政年份:2007
-
负责人:Peter Shawn Bearman
-
依托单位:
Social Determinants of the Autism Epidemic
-
批准号:8119452
-
项目类别:
-
资助金额:$79.7万
-
财政年份:2007
-
负责人:Peter Shawn Bearman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: